Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Aurobindo Pharma Profit & Loss Annual
Trade1,236.35 +12.70 (1.04%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 29,001.87 | 24,855.38 | 23,455.49 | 24,774.62 |
| Total Revenue | 29,001.87 | 24,855.38 | 23,455.49 | 24,774.62 |
| Costof Revenue Total | 12,602.90 | 12,325.90 | 11,053.50 | 10,805.28 |
| Gross Profit | 16,398.97 | 12,529.48 | 12,401.99 | 13,969.34 |
| Selling/ General/ Admin Expenses Total | 3,922.94 | 8,189.45 | 7,593.01 | 8,108.66 |
| Depreciation/ Amortization | 1,521.66 | 1,244.58 | 1,126.52 | 1,055.39 |
| Unusual Expense( Income) | 191.86 | 23.96 | 244.00 | -2,814.58 |
| Other Operating Expenses Total | 6,633.03 | 518.34 | 316.95 | 317.35 |
| Total Operating Expense | 24,872.39 | 22,341.74 | 20,399.22 | 17,540.91 |
| Operating Income | 4,129.48 | 2,513.64 | 3,056.27 | 7,233.71 |
| Interest Inc( Exp) Net- Non- Op Total | -2,680.90 | -316.80 | 334.70 | 110.20 |
| Other Net | 518.60 | 117.31 | 206.99 | 239.98 |
| Net Income Before Taxes | 4,379.99 | 2,612.50 | 3,372.74 | 7,343.59 |
| Provisionfor Income Taxes | 1,211.02 | 684.85 | 725.63 | 2,009.77 |
| Net Income After Taxes | 3,168.97 | 1,927.65 | 2,647.11 | 5,333.82 |
| Minority Interest | 4.00 | -0.15 | 1.04 | 1.02 |
| Net Income Before Extra Items | 3,172.97 | 1,927.50 | 2,648.15 | 5,334.84 |
| Net Income | 3,172.97 | 1,927.50 | 2,648.15 | 5,334.84 |
| Income Availableto Com Excl Extra Ord | 3,172.97 | 1,927.50 | 2,648.15 | 5,334.84 |
| Income Availableto Com Incl Extra Ord | 3,172.97 | 1,927.50 | 2,648.15 | 5,334.84 |
| Diluted Net Income | 3,172.97 | 1,927.50 | 2,648.15 | 5,334.84 |
| Diluted Weighted Average Shares | 58.59 | 58.59 | 58.59 | 58.59 |
| Diluted EPS Excluding Extra Ord Items | 54.16 | 32.90 | 45.20 | 91.05 |
| Diluted Normalized EPS | 56.53 | 33.03 | 47.45 | 57.91 |
| Research Development | - | 395.10 | 652.40 | 688.10 |
| Gain( Loss)on Saleof Assets | - | 132.30 | 760.10 | -1,411.20 |
| DPS- Common Stock Primary Issue | - | 3.00 | 9.00 | 4.00 |
*All figures in crores except per share values
Aurobindo Pharma Quick Links
Aurobindo Pharma Dividend Aurobindo Pharma Bonus Aurobindo Pharma News Aurobindo Pharma AGM Aurobindo Pharma Rights Aurobindo Pharma Splits Aurobindo Pharma Board Meetings Aurobindo Pharma Key Metrics Aurobindo Pharma Shareholdings Aurobindo Pharma Balance Sheet Aurobindo Pharma Cashflow Aurobindo Pharma Q1 Results Aurobindo Pharma Q2 Results Aurobindo Pharma Q3 Results Aurobindo Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)